![]() |
市场调查报告书
商品编码
1368744
麸酰胺酸市场规模 - 按类型、形式、应用、来源和预测,2023 年至 2032 年Glutamine Market Size - By Type, Form, Application, Source & Forecast, 2023 - 2032 |
麸酰胺酸市场规模预计从 2023 年到 2032 年复合年增长率将达到 3.4%,这主要是由于各行业对必需胺基酸重要性的认识不断提高。运动员和健身爱好者对营养补充剂的认识很高,他们正在转向麸酰胺酸,因为它具有肌肉恢復和增强免疫系统的特性。
此外,消费者健康意识的提高导致对含有麸酰胺酸的膳食补充剂的需求不断增长。根据 NCBI 的数据,2020 年 3 月,英国维生素销售额增长了 63%。同样,美国复合维生素的需求也有所增长,同年销售额达到 51.2%。
麸酰胺酸市场根据类型、形式、来源、应用和地区划分。
预计到 2032 年,D-谷氨酰胺细分市场将出现大幅增长。D-谷氨酰胺是 L-谷氨酰胺的天然立体异构体,由于其在製药和食品行业的应用而受到广泛关注。它的特点是具有更高的稳定性和优异的生物利用度,使其成为各种製剂的有吸引力的选择。随着製药和食品行业的不断扩张,D-谷氨酰胺类细分市场预计将蓬勃发展,以满足这些行业不断变化的需求。
由于麸酰胺酸在製药业中发挥着至关重要的作用,特别是在细胞培养基中以及作为肠外营养产品配方的重要组成部分,预计药品应用领域将在 2023-2032 年出现显着增长。它在支持免疫系统和促进组织修復方面的作用使其成为多种药物中的宝贵成分。随着药品研发的不断推进,预计未来几年对麸酰胺酸的需求将进一步上升。
受人口老化、医疗保健支出增加和製药业强劲等因素的推动,到 2032 年,欧洲麸酰胺酸市场规模将获得巨额收入。此外,欧洲食品安全局 (EFSA) 对与麸酰胺酸在免疫系统中的作用相关的某些健康声明的认可,增强了其在该地区的吸引力。由于重视健康和保健,欧洲预计将继续为全球麸酰胺酸市场做出巨大贡献。
Glutamine market size is expected to record 3.4% CAGR from 2023 to 2032, primarily due to the increased awareness of the importance of essential amino acid in various sectors. There is high awareness about nutritional supplements among athletes and fitness enthusiasts, who are turning to glutamine for its muscle recovery and immune system-boosting properties.
Furthermore, the rising health consciousness among consumers has led to a growing demand for dietary supplements that contain glutamine. According to the NCBI, in UK, the vitamin sales increased by 63% in March 2020. Similarly, the U.S. reported rise in demand for multivitamins as the sales reached 51.2% in the same year.
Glutamine market is divided based on type, form, source, application, and region.
The D-glutamine segment is predicted to witness substantial growth through 2032. D-glutamine, a naturally occurring stereoisomer of L-glutamine, has garnered considerable attention due to its applications in the pharmaceutical and food industries. It is characterized by its higher stability and superior bioavailability, making it an attractive option for various formulations. As the pharmaceutical and food industries continue to expand, the D-glutamine type segment is expected to flourish, catering to the evolving needs of these sectors.
The pharmaceuticals application segment is anticipated to observe significant growth over 2023-2032 as glutamine plays a vital role in the pharmaceutical industry, particularly in cell culture media and as an essential component for the formulation of parenteral nutrition products. Its role in supporting the immune system and facilitating tissue repair has made it a valuable ingredient in a variety of medications. As pharmaceutical R&D continue to advance, the demand for glutamine is anticipated to rise further in the coming years.
Europe glutamine market size will gain massive revenues by 2032, driven by factors such as a growing aging population, increased healthcare expenditure, and a strong pharmaceutical sector. Additionally, the European Food Safety Authority's (EFSA) recognition of certain health claims related to glutamine's role in the immune system has heightened its appeal in the region. With an emphasis on health and wellness, Europe is expected to continue its substantial contribution to the global glutamine market.